BioSpace News Archive

GE Healthcare invests in a unique approach to cutting-edge CT technology and acquires Prismatic Sensors AB, a leader in Deep Silicon detector technology for photon counting computed tomography (PCCT)

High sensitivity and high negative predictive value (NPV) observed for ruling out the risk of preeclampsia

Fireside chat at Piper Sandler 32nd Annual Virtual Healthcare Conference to be webcast on November 24

ADC Therapeutics SA (NYSE: ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent and targeted antibody drug conjugates (ADCs) for patients with hematological malignancies and solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for loncastuximab tesirine (Lonca)

THINK Surgical, an innovator in the field of orthopedic active robot surgery, announced today that the Food and Drug Administration (FDA) has cleared the second-generation of the TSolution One Total Knee Application

Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference,

Interim review in newly diagnosed glioblastoma patients provides OS18 data, demonstrates immunogenicity and tolerability in a majority of patients

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leader in discovery, development and commercialization of innovative cancer medicines, today announced that the company was officially listed and it’s shares commenced trading on the Main Board of The Stock Exchange.

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced it has entered into an agreement, effective November 3, 2020, with Blue Cross Blue Shield of Illinois for its Commercial PPO and Medicare Advantage membership.

Monte Rosa Therapeutics, a biotechnology company focused on developing precision medicines to degrade disease-causing proteins, today announced its participation in the 32nd Annual Piper Sandler Virtual Healthcare Conference taking place November 30-December 3, 2020. Markus Warmuth, M.D., CEO of Monte Rosa, will be presenting a corporate overview on November 30, 2020.